Aaron Cooper
Vice President - Early Discovery Arsenal Biosciences, Inc.
Seminars
Wednesday 16th September 2026
Targeting Prostate Cancer: Arsenal Bio’s Programmable Circuit T (PCT) Cell Platform & the Development of AB-3028
2:05 pm
- Strengthening CAR-T selectivity with logic gating to safely target solid tumors
- Enhancing CAR-T potency with modular engineering to endure the tumor microenvironment
- Enabling translational readouts to validate cell therapy module function in the clinic
